Balance Sheet
Accounts PayablesAssetsCommon EquityLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Payables (2023 - 2025)

Lamy (LMMY) has disclosed Payables for 3 consecutive years, with $212302.0 as the latest value for Q4 2025.

  • Quarterly Payables changed N/A to $212302.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $212302.0 through Nov 2025, changed N/A year-over-year, with the annual reading at $29000.0 for FY2024, 0.0% changed from the prior year.
  • Payables hit $212302.0 in Q4 2025 for Lamy, up from $29000.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $212302.0 in Q4 2025 to a low of $29000.0 in Q1 2023.
  • Historically, Payables has averaged $51912.8 across 3 years, with a median of $29000.0 in 2023.
  • Biggest YoY gain for Payables was 0.0% in 2024; the steepest drop was 0.0% in 2024.
  • Year by year, Payables stood at $29000.0 in 2023, then changed by 0.0% to $29000.0 in 2024, then surged by 632.08% to $212302.0 in 2025.
  • Business Quant data shows Payables for LMMY at $212302.0 in Q4 2025, $29000.0 in Q3 2024, and $29000.0 in Q2 2024.